Question
========

In Behçet\'s disease (BD), vasculitis involving blood vessels of nearly all sizes and types may underlie the diverse tissue and organ involvement. Loss of function mutations in the *CECR1* gene (encoding adenosine deaminase 2) have recently been shown to cause a recessive genetic disease, deficiency of adenine deaminase 2 (DADA2). Patients with DADA2 exhibit systemic vasculopathy characterized by intermittent fevers, skin rash, and neurovascular manifestations along with other features that can lead to a diagnosis of polyarteritis nodosa. Patients homozygous for the *CECR1* p.Gly47Arg mutation are reported in two non-consanguineous Turkish families and this mutation is found at low frequency in the Turkish population. We therefore attempted to determine whether some BD cases may be explained by adenosine deaminase 2 deficiency and whether this mutation contributes to BD risk in patients of Turkish ancestry.

Methods
=======

Turkish BD patients (n = 1,609) and controls (n = 1,519) were genotyped for p.Gly47Arg mutations in the *CECR1* gene using a Sequenom assay. The assay interrogated two mutant alleles of the first nucleotide of the Gly47 codon that both encode the glycine to arginine missense change.

Results
=======

We found p.Gly47Arg mutations in 4 BD patients and 3 healthy controls. No individuals (neither cases or controls) carried two mutant alleles. The carrier frequency for p.Gly47Arg mutations was 0.002 in cases and in controls.

Conclusions
===========

These data show that the carrier rate of *CECR1* p.Gly47Arg mutations is very low in Turkish Behcet\'s patients and not different from controls, suggesting no contribution to Behcet\'s disease.
